Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04864184 · ClinicalTrials.gov registry record · NA

Effects of Breathing Patterns on Post-prandial Vascular Function

A NA study, sponsored by Texas State University.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT04864184: Completed NA study, sponsored by Texas State University.

NCT04864184 is a NA study that has completed, run by Texas State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04864184, a NA study, has completed, sponsored by Texas State University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

The purpose of this study is investigate the effects of two different breathing styles on postprandial vascular function and oxidative stress markers. Participants will complete 2 breathing conditions in random order.

Primary Outcome

Ultrasound-derived images of the brachial artery pre- and post-suprasystolic cuff inflation will yield flow-mediated dilation values. These are indices are endothelium-dependent vasodilation.

Interventions

  • BEHAVIORAL Slow breathing
  • BEHAVIORAL Normal physiologic rate breathing

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2020-12-01
Est. Completion 2021-09-30
Phase NA
Texas State University

10 total trials

What the finished NCT04864184 record still lists

NCT04864184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Slow breathing is the first listed.

NCT04864184 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04864184 about?

NCT04864184 is a clinical study titled "Effects of Breathing Patterns on Post-prandial Vascular Function". The purpose of this study is investigate the effects of two different breathing styles on postprandial vascular function and oxidative stress markers. Participants will complete 2 breathing conditions in random order.

What is the current status of trial NCT04864184?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-12-01. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT04864184?

The interventions under investigation include: Slow breathing (BEHAVIORAL), Normal physiologic rate breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04864184?

This trial is sponsored by Texas State University, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04864184's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04864184, the US trial registry maintained by the National Library of Medicine. NCT04864184 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.